← BIOLIFE SOLUTIONS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $8.2m $11.0m $19.7m $27.4m $48.1m $119.2m $161.8m $143.3m $82.3m $96.2m
Revenue from Contract with Customer, Including Assessed Tax $8.2m $11.0m $19.7m $27.4m $48.1m $119.2m $161.8m $143.3m $82.3m $96.2m
Cost of Revenue $3.4m $4.3m $6.2m $8.8m $39.1m $82.1m $107.9m $96.5m $28.6m $34.1m
Gross Profit (derived) $4.8m $6.7m $13.5m $18.6m $9.0m $37.0m $53.8m $41.3m $50.1m $62.1m
Operating Expenses $9.6m $7.8m $9.9m — — — — — — —
Operating Income (Loss) ($4.9m) ($1.1m) $3.7m ($220k) ($5.6m) ($33.9m) ($145.5m) ($70.8m) ($7.1m) ($16.6m)
Additional Financial Items
Amortization of Intangible Assets — — — $1.1m $3.0m $8.2m $9.7m $5.2m $2.7m $263k
Gain (Loss) on Investments — — — — $1.3m $0 $697k $0 ($4.1m) $0
Goodwill, Impairment Loss — — — — $0 $0 — — — —
Income (Loss) from Continuing Operations before Income Taxes, Domestic — $2.5m $3.3m $3.2m $597k ($27.3m) ($146.1m) ($67.3m) $11.4m ($12.0m)
Income (Loss) from Continuing Operations, Per Basic Share — ($1) $0 ($0) $0 ($0) ($3) ($2) ($0) ($0)
Income (Loss) from Continuing Operations, Per Diluted Share — ($1) $0 ($1) ($0) ($0) ($3) ($2) ($0) ($0)
Income (Loss) from Equity Method Investments — ($1.0m) ($672k) ($739k) $0 — — — — —
Other Income $2k $350 $281k ($13k) $0 $289k $704k $1.3m $497k $1.8m
Preferred Stock Dividends, Income Statement Impact — $212k $339k — — — — — — —
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — $2.5m $3.3m ($3.2m) ($597k) ($27.8m) ($144.8m) ($66.3m) ($11.4m) ($12.1m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — $2.5m $3.3m $3.2m $597k $27.8m $144.8m $66.3m ($11.4m) ($12.1m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent — — — — — — $140.0m $49.4m ($8.8m) $7.5m
Net Income (Loss) Attributable to Parent ($6.9m) ($2.5m) $3.3m ($1.7m) $2.7m ($7.6m) ($139.8m) ($66.4m) ($20.2m) ($4.6m)
Net Income (Loss) Available to Common Stockholders, Basic — ($2.7m) $2.9m ($1.7m) $2.5m ($7.6m) ($139.8m) ($66.4m) — —
Net Income (Loss) Attributable to Noncontrolling Interest ($1.2m) $0 — — — — — — — —
Earnings Per Share, Basic — ($0.21) $0.18 ($0.09) $0.09 ($0.20) ($3.29) ($1.52) ($0.44) ($0.09)
Earnings Per Share, Diluted ($0.54) ($0.21) $0.14 ($0.09) ($0.03) ($0.20) ($3.29) ($1.52) ($0.44) ($0.10)
Weighted Average Number of Shares Outstanding, Basic — — 16.3m 19.5m 27.3m 38.5m 42.5m 43.7m 46.1m 47.8m
Weighted Average Number of Shares Outstanding, Diluted — — 21.6m — — — — 43.7m 46.1m 48.6m
Research and Development Expense $2.0m $1.2m $1.3m $3.2m $6.7m $11.8m $14.8m $18.8m $7.9m $7.6m
General and Administrative Expense $4.6m $4.5m $6.0m $8.9m $14.6m $32.4m $47.7m $55.7m $40.5m $45.5m
Other Nonoperating Income (Expense) $2k $350 $281k ($13k) $0 $289k $704k $1.3m $497k $1.8m
Business Combination, Acquisition Related Costs — — — $940k $668k $1.6m $18k $0 — —
Costs and Expenses — — — $27.6m $53.7m $153.1m $307.3m $214.1m $89.4m $78.7m
Current Income Tax Expense (Benefit) — — — — $33k $9k $216k $231k — —
Interest Expense — $190k $5k $5k — — — — — —
Selling and Marketing Expense $3.0m $2.1m $2.6m $4.7m $6.4m $14.0m $21.6m $24.6m $9.6m $9.8m
Income Tax Expense (Benefit) $0 $0 $3.3m ($1.5m) ($3.3m) ($20.1m) ($5.0m) $169k ($38k) $49k
Interest Income (Expense), Nonoperating, Net — — — $501k $58k ($432k) ($687k) ($1.8m) ($719k) $2.7m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.